Clin Mol Hepatol.  2017 Sep;23(3):212-218. 10.3350/cmh.2017.0105.

Current status of and strategies for hepatitis C control in South Korea

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. dyk1025@yuhs.ac
  • 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 3Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
  • 4Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
  • 5Department of Preventive Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
  • 6Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Korea.

Abstract

Chronic hepatitis C (CHC) is caused by hepatitis C virus (HCV) infection. HCV infection causes acute hepatitis, and the majority of those infected progress to chronic hepatitis, and some of them develop cirrhosis and hepatocellular carcinoma. Transmission of HCV is parenteral, and the major transmission routes include drug abuse, insecure injections or medical procedures, contaminated syringes or needles, sexual contact with an HCV-infected person, vertical infection of newborns by infected mothers, the transfusion of blood or blood products contaminated with viruses, and organ transplants. As no vaccine against HCV is available, HCV management involves blocking routes of transmission transmission, screening for HCV infection, and protecting liver disease progression by treatment. Highly potent oral direct antiviral agents are now available. Therefore, early detection through nation-wide screening program and appropriate treatment should be implemented to improve the quality of life of patients with HCV. Furthermore, for the effective HCV control in South Korea, The organization of an "˜integrated national viral hepatitis control system' is desirable.

Keyword

Hepatitis C virus; Status; Control

MeSH Terms

Antiviral Agents
Carcinoma, Hepatocellular
Fibrosis
Hepacivirus
Hepatitis C*
Hepatitis C, Chronic
Hepatitis*
Hepatitis, Chronic
Humans
Infant, Newborn
Korea*
Liver Diseases
Mass Screening
Mothers
Needles
Quality of Life
Substance-Related Disorders
Syringes
Transplants
Antiviral Agents
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr